BIO-TECHNE Corp vs Tempus AI — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Tempus AI trades at $49.01 (market cap $8.69B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| TECH | TEM | |
|---|---|---|
Market Cap | $11.16B | $8.69B |
Sector | Health | Broad Market / Factor |
52-Week High | $72.12 | $103.25 |
52-Week Low | $43.31 | $42.37 |
Enterprise Value | $11.24B | $9.37B |
Dividend Yield | 0.45% | — |
Trailing returns across standard periods
Latest headlines on both assets
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →